Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease
Clinical trial NCT04693520 · COMPLETED
Trial details
- NCT number
- NCT04693520
- Sponsor
- Alzheon Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-06-20
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.